CARDIAC DIAGNOSTIC & MONITORING SYSTEMS HEALTHCARE PROFESSIONALS
Insertable Cardiac Monitors
You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
Insertable Cardiac Monitors
The LINQ II™ Insertable Cardiac Monitor (ICM) with TruRhythm™ Detection is the world's most accurate ICM1-4 personalised for the patient's lifestyle and customised for the clinician's workflow. LINQ II provides up to 4.5 years of cardiac monitoring and is MR-Conditional at 3.0 and 1.5 Tesla with no-post insertion waiting period.5*
The Reveal LINQ™ Insertable Cardiac Monitor (ICM) with TruRhythm™ Detection is the world's smallest6, most accurate ICM.1-4 Reveal LINQ™ ICM provides up to 3 years of cardiac monitoring and is MR-Conditional at 3.0 and 1.5 Tesla with no-post insertion waiting period.7**
The Reveal™ XT Insertable Cardiac Monitor (ICM) provides proven arrhythmia detection for up to 3 years and is MR Conditional at 3.0 and 1.5 Tesla with a 6-week post-insertion waiting period .8†
* LINQ™ II ICM has been demonstrated to pose no known hazards in a specified MR environment with specified conditions of use. Please see the LINQ II™ ICM Clinician Manual or MRI Technical Manual for more details.
** Reveal LINQ™ ICM has been demonstrated to pose no known hazards in a specified MR environment with specified conditions of use. Please see the Reveal LINQ™ ICM Clinician Manual or MRI Technical Manual for more details.
† Reveal™ XT ICM has been demonstrated to pose no known hazards in a specified MR environment with specified conditions of use. Please note that patients must wait 6 weeks post-insertion before having an MRI scan. Please see the Reveal™ XT ICM Clinician Manual or MRI Checklist for more details.
Product names on this page are trademarks or registered trademarks of Medtronic.
Nölker G, Mayer J, Boldt LH, et al. Performance of an Implantable Cardiac Monitor to Detect Atrial Fibrillation: Results of the DETECT AF Study. J Cardiovasc Electrophysiol. December 2016;27(12):1403-1410.
Confirm Rx™ ICM DM3500 FDA Clearance Letter. 2017.
Biotronik BioMonitor 2 Technical Manual. 2017.
Pürerfellner H, Sanders P, Sarkar S, et al. Adapting detection sensitivity based on evidence of irregular sinus arrhythmia to improve atrial fibrillation detection in insertable cardiac monitors. Europace. November 1, 2018;20(FI_3):f321-f328
Refer to the LNQ22 ICM Clinician Manual for usage parameters
ICM Size Comparison Guide. Medtronic data on file. 2019.
Refer to the Reveal LINQ™ ICM Clinician Manual for usage parameters.
Reference the Reveal™ XT ICM Clinician Manual for usage parameters.